Neuropsychiatric Features of a Cohort of Patients with Systemic Lupus Erythematosus
Open Access
- 20 November 2012
- journal article
- Published by Hindawi Limited in ISRN Rheumatology
- Vol. 2012, 1-9
- https://doi.org/10.5402/2012/989218
Abstract
In order to establish if neuropsychiatric systemic lupus erythematosus (NPSLE) can be identified by any characteristic other than those used to diagnose the neuropsychiatric (NP) disease itself, we retrospectively reviewed 98 systemic lupus erythematosus (SLE) patients followed over a mean period of 10 years. NPSLE was identified in 22 patients. Stroke and generalized seizures were the most frequent NP manifestations. The NPSLE and non-NPSLE groups were similar with regard to demographic characteristics, ACR criteria, serum autoantibodies, and frequency of hypertension and hypercholesterolemia. Of note, compared to the non-NPSLE group, NPSLE was associated with a higher frequency of smoking (78 versus 26%), organ damage (73 versus 34%), and cumulative mortality rate (14 versus 7%). The series of patients was further analysed according to the presence of antiphospholipid syndrome (APS). Significantly, the interval between the onset of NP disease and SLE diagnosis was shorter in the APS− ( years) than in the APS+ ( years) groups. Recurrence and/or persistence of NP events were only documented in the APS− group. Overall cumulative mortality was highest in NPSLE and in APS+ patients with inadequate anticoagulation control, identifying an aspect that requires improved vigilance and the development of novel therapeutic modalities.
Keywords
This publication has 56 references indexed in Scilit:
- The Emerging Link Between Autoimmune Disorders and Neuropsychiatric DiseaseThe Journal of Neuropsychiatry and Clinical Neurosciences, 2011
- The Euro-lupus project: epidemiology of systemic lupus erythematosus in EuropeLupus, 2009
- Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosusAnnals Of The Rheumatic Diseases, 2009
- Potential effects of cyclosporin a on coronary vasomotor function in young patients with systemic lupus erythematosus: Comment on the article by Hirata et alArthritis & Rheumatism, 2007
- Association of cerebrospinal fluid anti-ribosomal P protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosusArthritis Research & Therapy, 2007
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Accuracy of anti–ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: An international meta‐analysisArthritis & Rheumatism, 2005
- Baseline characteristics of a multiethnic lupus cohort: PROFILELupus, 2002
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- Connective tissue disease and the skinClinical and Experimental Dermatology, 1984